Leading the Way in Life Science Technologies

GEN Exclusives

More »

Market and Technology Analysis

More »
April 10, 2014

Clinical Trials Focusing on Fat for Regenerative Medicine

Find out how adipose-derived stem cells are gaining weight among researchers.

Clinical Trials Focusing on Fat for Regenerative Medicine

The use of adipose tissue in cosmetic and reconstructive surgery is well documented. This report focuses on the trials assessing its potential for the regenerative medicine field. [Huffington Post]

  • Clinical trials assessing the utility of adipose-derived stem cells for regenerative medicine in various disease classes is the focus of this report.


    • The report is our sequel to last week’s report focusing on the emerging role of adipose-derived stem cells in regenerative medicine.
    • There are ongoing clinical trials worldwide deploying stromal vascular fraction (SVF) or other cellular classes in various disease classes.
    • The vast majority of these trials utilize autologous cells (very few are allogeneic).
    • The majority of these trials are occurring outside the U.S.
    • The trials are sponsored by academic or industry (60:40 Academia: Industry breakout).
    • Taken together these data provide a framework for tracking the ongoing interest in the deployment of fat and its associated cells in regenerative medicine.

Related content